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Adenovirus IVa2 protein is essential and multifunctional, with roles in encapsidation and transcriptional activation of the Major Late
Promoter (MLP), but the importance of the transcriptional function to viability has not been assessed. To address this question, viral genomes
with multiple nonbinding mutations in the MLP downstream elements DE1 and DE2, alone or in combination with nonbinding mutations in
the UPE (USF0), were constructed. The results show that DE1/2 and the UPE are functionally redundant, suggesting an important role of
IVa2 protein in the activation of the MLP in vivo. Previously, a virus (vIVa2) expressing a 40-kDa IVa2 isoform was created. Neither the
DE1/2 mutations nor the USF0 mutations could be recovered in this genetic background. These results suggest that this 40-kDa isoform can
play a role in transcription.
D 2004 Elsevier Inc. All rights reserved.Keywords: IVa2 protein; Transcription; DE1/2Introduction
The adenovirus IVa2 protein is multifunctional, with
roles in encapsidation (Zhang and Imperiale, 2000, 2003;
Zhang et al., 2001) and transcriptional activation of the
MLP (Tribouley et al., 1994). Previous results with both
truncations and null mutations (Zhang and Imperiale,
2003) have shown that it is essential for virus viability,
but the relative importance of the two functions has not
been easy to address because no mutations have been
created that clearly separate the two functions. Virus
genomes with an opal codon at position 6 of the IVa2
ORF were viable and expressed a 40-kDa IVa2 isoform,
either initiated at the second methionine of the IVa2 ORF
or encoded by a defective recombinant genome in which
the first methionine had been removed (Pardo-Mateos and
Young, 2004). The 40-kDa species encoded in the latter
case is capable of binding to both the packaging sequence
and DE1,2. Although viruses expressing this isoform were0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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the encapsidation and transcriptional functions of this
isoform, as compared to the 55-kDa species, were not
assessed, leaving the importance of each role of the
protein for viral replication unresolved. The construction
of a virus genome with mutations in the downstream
elements of the MLP, designed to prevent the binding of
protein IVa2, might be able to address the question of its
importance in transcriptional activation in the context of
the virus.
During the replicative cycle of adenovirus, there is a
switch from early to late gene expression in which the
Major Late Promoter (MLP) is fully activated. This
activation requires replication initiation (Thomas and
Mathews, 1980) and the expression of the viral IVa2
protein. IVa2 mRNA is detected shortly after DNA repli-
cation begins (Binger and Flint, 1984; Huang et al., 2003;
Lin and Flint, 2000), and its expression depends on the
titration, by the accumulating pool of viral genomes, of a
cellular repressor of the IVa2 promoter (Huang et al.,
2003; Lin and Flint, 2000). The protein binds to the
MLP DE1 and DE2 transcription elements (Tribouley et
al., 1994). DE1 is bound by DEF-A, a heterodimer of the
55-kDa IVa2 protein and a protein of 40-kDa apparent
molecular weight. DE2 is bound in its 5V half by DEF-B
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A. The downstream elements were first identified during
the construction of an adenovirus-SV40 hybrid (Mansour
et al., 1986) and they were located by DNAseI foot-
printing analysis (Jansen-Durr et al., 1989). Analysis of
these elements in an ectopically located MLP-h-globin
cassette showed lower levels of transcription when these
elements were mutated (Leong et al., 1990). In combined
infection– transfection experiments, the binding of the
IVa2 complexes to DE1 and DE2 was necessary for high
levels of transcription from a reporter plasmid (Lutz and
Kedinger, 1996; Monde´sert et al., 1992; Tribouley et al.,
1994). However, a multiple mutation in DE1 had no effect
on viral replication either alone or in combination with a
multiple mutation in the UPE (Reach et al., 1991). DE1 is
the smaller element of the two and only binds DEF-A,
whereas DE2 binds DEFB and also DEFA. Thus, although
the mutation of the smaller downstream element shows no
mutant phenotype, the mutation of both elements might do
so. It is known that the MLP elements show functional
redundancy (Young, 2003). For example, the CAAT5
mutation, which contains individual changes at five posi-
tions in the CAAT box, had no discernable phenotype
(Song and Young, 1998). Similarly, USF0, with four
changes that render UPE unable to bind USF in gel-shift
assays, had no significant replication deficiency (Reach et
al., 1990). However, when these mutations were com-
bined, the level of viral replication diminished and so did
the level of late transcription (Song and Young, 1998).
Therefore, mutations in both DE1 and DE2 were con-
structed and shown to be incapable of binding IVa2
protein. They were then placed in the context of the virus
to examine the role of the downstream elements in the
activation of the MLP. The phenotypes of these mutations,
either alone or in combination with other MLP and IVa2
mutations, were analyzed in an attempt to discern the
importance of the transcriptional function of the IVa2
protein.Fig. 1. (A) MLP-direction sequence showing the DE1 and DE2a/DE2b
elements (boxed). Open box: DE1; hatched box: DE2a; checkered box:
DE2b. Upward arrows: mutations made previously which abolished
formation of complexes in EMSA (Monde´sert et al., 1992). Bold or
underlined: residues whose methylation interferes with complex formation
in the MLP-direction strand or in the DNA-polymerase sense strand,
respectively (Monde´sert et al., 1992). Downward arrows: mutations made
for the construction of vDE1,2. (B) DNA-polymerase sense strand
showing the mutations for vDE1,2 construction (lower case). (C)
Conserved amino acid sequence of DNA polymerase (shown in the
COOH to NH2 direction).Results
Mutations in the downstream MLP elements that do not bind
IVa2 protein
The IVa2 protein has roles in both transcription and
encapsidation but the relative importance of the two func-
tions to virus viability has not been determined. In an
attempt to clarify this, a virus genome in which the IVa2
transcription binding sites (DE1 and DE2) were compre-
hensively mutated was constructed. The aim was to create a
DNA sequence incapable of binding IVa2 protein so that its
contribution to transcriptional activation of the MLP could
be unambiguously assessed.
The mutations in DE1 were the same as those previously
described (Reach et al., 1991) while mutations in DE2 werechosen to change as many as possible of the nucleotides
shown to be involved in binding of IVa2 protein by
methylation (Monde´sert et al., 1992) or mutation in previous
gel shift analyses (Lutz and Kedinger, 1996), while main-
taining the amino acid sequence of the DNA polymerase in
the complementary DNA strand (Fig. 1).
Electrophoretic mobility assays were performed to test
the ability of these new mutations of the DE1,2 elements to
be bound by IVa2 protein. Assays with nuclear extracts from
adenovirus-infected cells and a probe spanning the DE1 and
DE2 elements show a specific species of mobility shift (Fig.
2A, lane 2). The intensity of the band is reduced by
competition with increasing amounts of a nonlabeled wild-
type probe (Fig. 2A, lanes 3–5) but is not reduced with a
nonlabeled probe carrying the DE1,2 mutations (Fig. 2A,
lanes 6, 7). The amounts of the wild type and mutated
unlabeled DE1,2 probes were shown to be the same (Fig.
2B). One concern with these results is that only a single
shifted band was observed, as compared with the multiple
species seen by others (Monde´sert et al., 1992; Tribouley et
al., 1994; Zhang and Imperiale, 2000). However, previous
results with this probe under identical experimental con-
ditions have shown that extracts from cells infected with a
virus expressing a 40-kDa isoform display a single lower-
migrating species, consistent with the binding of the smaller
isoform (Pardo-Mateos and Young, 2004). We suggest that
the mutated elements cannot compete with the binding of
IVa2 protein to the wild-type sequence. By inference, the
mutated sequence is incapable of binding the protein in
vitro.
Construction of a virus containing the DE1,2 mutations
To test the phenotype of the DE mutations in vivo, a
plasmid carrying the mutations (pMR2-DE1,2) was co-
transfected with pPM100, an adenovirus full-length plasmid
that contains a lethal mutation in the DNA polymerase
(Pardo-Mateos and Young, 2004). Two co-transfections,
Fig. 3. (A) Plaque assay of vWT- and vDE1,2-infected A549 cells. (B)
One-step replication analysis of vDE1,2 compared with that of the WT
counterpart. Plates were titrated at 3, 12, 14, 16, 18, 20, 22, 24, 48, and
68 h.p.i.
Fig. 2. (A) Electrophoretic mobility shift assay (EMSA) with nuclear
extracts (NE) from uninfected cells (UIC) or from adenovirus-infected cells
(Ad-cells) and 1.6 nM of a labeled duplex probe spanning the DE1,2
elements. Competition with 10-, 25-, and 50-fold molar excess of the wild-
type unlabeled duplex probe (wtDE1/2) or 25- and 50-fold molar excess of
the mutated probe (mDE1/2). (B) Agarose gel showing same amounts of
wild type (wt) and mutated (m) unlabeled duplex probe.
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plate in each transfection yielded virus. One yield contained
only wild-type reconstituted virus but the other had a mixed
population, based on the presence of a flanking restriction
site marker analysis of Hirt DNA (Materials and methods).
Individual plaques were isolated, a potential mutation-con-
taining isolate was identified, the infected cell DNA was
sequenced, and the virus plaque-purified again. The muta-
tion-containing virus is referred to as vDE1,2.
A further plaque assay was performed with the plaque-
purified stock of vDE1,2 in parallel with one with vWT,
which has the same pPM100 genetic background (Fig. 3A).
Plaques produced by vDE1,2 are smaller than those of vWT.
A one-step replication cycle in A549 cells was performed at
a MOI of 10 (Fig. 3B). Although the eclipse values for
vDE1,2 were apparently considerably lower that those of
vWT, the titers during the exponential rise period and of the
final yields were at most 5-fold lower than those of vWT-
infected cells. These data show that vDE1,2 has a minor
deficiency in viral replication.
Because DE1 and DE2 have been shown to be important
in the late activation of the MLP when placed in ectopic
locations (Leong et al., 1990; Mansour et al., 1986), we
expected the deficient replication of vDE1,2 to be attribut-
able to a deficiency in late transcription. Once DNA
accumulation was shown to be the same as that of vWT
(Fig. 4A), late proteins and mRNAs were examined. At 21
h, there is a difference in late protein accumulation, more
apparent for some proteins (penton base, V, pVI, and VI)
than others (e.g. fiber). This differential becomes less
noticeable at 31 h (Fig. 4B). Northern analysis of late
mRNAs (Fig. 4C) also showed minor differences in accu-
mulation depending on the specific species. For example,
levels of fiber mRNA at 24 h are very similar in vDE1,2-
and vWT-infected cells, but differences are more noticeablein L3 pVI and hexon mRNAs isolated at 15 and 18 h (Fig.
4C). Other data at various time points suggest that differ-
ences in late mRNA accumulation are, at best, minor. This is
reminiscent of the phenotype of the virus with mutations in
the UPE, termed USF0 (Reach et al., 1990).
IVa2 protein accumulation was examined in nuclear
extracts from infected cells. It was shown reproducibly to
accumulate to higher levels in vDE1,2-infected cells than in
those infected with vWT (Fig. 5A). This can be easily seen
in comparison with late proteins from the same extracts
(Fig. 5B). There is a correspondingly greater accumulation
of IVa2 mRNA in vDE1,2-infected than in vWT-infected
cells (Fig. 5C).
These data show that mutations that abrogate binding of
the IVa2 protein in vitro have minor effects in vivo with
respect to late transcription. However, it is well known that
the transcriptional elements of the MLP are functionally
redundant. Moreover, the IVa2 protein might be recruited to
the MLP by protein–protein interactions with other MLP-
bound transcription factors.
Coupling the DE1,2 mutations to the USF0 mutations
One way to test the idea of functional redundancy is to
create viral genomes with mutations in more than one
element (reviewed in Young, 2003). For example, cells
infected with virus USF0, which has multiple mutations in
  
Fig. 4. (A) DNA accumulation of vWT- and vDE1,2-infected cells at 10, 12, 14, and 30 h.p.i. (B) Late protein accumulation of vWT- and vDE1,2-infected cells
at 21 and 31 h.p.i. A polyclonal antibody raised against capsid proteins was used. Actin was used as loading control. (C) L5 and L3 RNA accumulation of
vWT- and vDE1,2-infected cells. The figure to the left shows accumulation of fiber mRNA at 24 h.p.i. using a probe that recognizes 687 nt of the fiber-specific
mRNAs and the figure to the right accumulation of pVI and hexon at 15 and 18 h.p.i. using a probe spanning 597 nt of the L3-specific mRNAs polyA family.
In both cases, 28S rRNA is used as loading control.
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containing mRNAs at 12 h but levels equal to those of vWT-
infected cells at 24 h (Reach et al., 1990). Viral replication is
close to normal. However, a virus containing the USF0
mutations plus a CAAT box mutation exhibited a very
defective accumulation of late transcripts at 12 and 24
h and a correspondingly deficient replication (Reach et al.,
1990). Furthermore, in vitro transcription assays haveFig. 5. (A and B) Western blot of protein from nuclear extracts of vWT- or
vDE1,2-infected cells at 24 h.p.i. (A) Anti-IVa2 N-terminus specific mouse
serum. (B) Polyclonal antibody raised against capsid proteins. (C) Northern
blot of vWT- and vDE1,2-infected cells at 15 and 18 h.p.i. using a probe
spanning 576 nt of the IVa2 specific mRNA. 28S rRNA is used as loading
control.shown an interaction between the factors that bind to UPE
and DE1,2 (Monde´sert and Kedinger, 1991) and infection–
transfection experiments have shown a functional interac-
tion between the two (Monde´sert et al., 1992). A virus
genome containing both USF0 and DE1,2 mutations might
be expected to show a major transcriptional phenotype.
Thus, we tried to create a virus with a genome containing
both mutations, using two different methods of construction.
In a co-transfection of pMR2-USF0/DE1,2 and pPM100,
two of three replicate plates yielded virus. Despite the low
probability of obtaining a USF0-only mutant genome (4%
against a 96% probability of a genome containing both
mutant elements), viral DNA from cells infected with
individual plaque isolates isolated from the two positive
transfections contained the USF0 mutations alone (Table 1).
This strongly suggests that the double mutation is lethal. To
confirm this observation, a second genetic method was used,
in which recombination efficiency in the mammalian cell is
not a factor, namely, the creation in E. coli of a full-length
adenovirus genome containing the mutations of interest. The
USF0 and DE1,2 mutations were constructed into a plasmid
containing a full-length infectious adenovirus genome
(McVey et al., 2002). Three transfections were performed
with this plasmid and 16 replicate dishes failed to yield
virus, but it was possible to rescue the lethal phenotype with
pAP6, which contains the wild-type sequence (Table 1).
This strongly suggests that the genome containing both sets
of mutations in UPE and DE1/2 is inviable. Direct analysis,
by both fluorescent focus assay and Western analysis, of
Table 1
Transfection of plasmids carrying the mutations into 293 cells
Transfecting plasmids
Transf.a Platesb
R. pl.c Yieldd Analysise
pPM100 +
pMR2-DE1,2
2 4 – 2 DE1,2; WT
pPM100 +
pMR2-USF0/DE1,2
1 3 – 2 USF0
pGenVec-USF0/DE1,2 3 16 – 0
3 pAP6 3
pPM100 + pAP12
(opal6/DE1,2)
1 3 – 3 DE1,2
pGenVec-opal6/DE1,2 1 2 – 0
1 pAP6 1
pPM100 + pAP13
(opal6/USF0)
1 3 – 1 USF0
a Number of transfections.
b Total number of plates.
c Rescuing plasmid.
d Number of plates that yielded virus.
e Analysis of the recovered virus by analyzing the DNA isolated by the Hirt
method from individual plaques.
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evidence for late protein accumulation. In contrast, cells
transfected with the wild-type genome revealed many cells
expressing hexon protein, and Western analysis showed
abundant late protein accumulation. In addition, a transfec-
tion with a genome containing the double mutation opal6-
M75L, which is incapable of yielding infectious virus
(Pardo-Mateos and Young, 2004), probably because of a
block to encapsidation, showed a lower number of fluores-
cent foci and evidence for protein accumulation. Taken
together, these results suggest that the inviability of the
USF0/DE1,2 genome is caused by a failure in transcription
from the MLP, They are congruent with the in vitro
transcription data (Monde´sert and Kedinger, 1991; Monde´-
sert et al., 1992) and consistent with the idea that binding of
the IVa2 protein, either directly to the downstream elements
or via protein–protein interactions, is important for tran-
scriptional activation of the MLP.
Coupling of the DE mutations to the IVa2 opal6 mutation
and the latter to the USF0 mutations
An opal stop codon at position 6 in the IVa2 ORF created
a virus genome that led to viable virus vIVa2 isolate #8
(Pardo-Mateos and Young, 2004). Cells infected with this
virus accumulate a 40-kDa IVa2 protein isoform able to
partially perform IVa2 function(s). This 40-kDa derivative is
still capable of binding to the DE1,2 elements (data not
shown), but the virus replicates less well than the wild type
and shows a lower accumulation of late proteins. It was of
interest to determine the phenotypes of viral genomes that
express the 40-kDa isoform in the context of an MLP
mutation.
A co-transfection was performed with a plasmid (pAP12)
carrying both opal6 and DE1,2 mutations and pPM100 andviral yields were obtained in all three replicate plates. None
of the plaques arising from the yields from the three plates
carried the opal6 mutation. Those examined in detail
contained only the DE1,2 mutation (Table 1), although the
probability of the recombination taking place such that it
would only include DE1,2 was 22% against 74% for
including both mutations, 1% WT, and 3% opal6. As
always, with this method of viral construction, a negative
result is not conclusive, and therefore both mutations were
constructed into a full-length plasmid. One transfection was
performed with two replicate plates and neither yielded
virus, but the marker rescue with pAP6 was successful
(Table 1). Both sets of genetic data indicate the lethality
of the double mutation.
A single co-transfection of a plasmid (pAP13) carrying
both opal6 and USF0 mutations and pPM100 yielded virus.
Analysis of the DNA from seven plaques showed that the
viruses contained only the USF0 mutations (Table 1),
although the probability of this happening was 23% as
opposed to 77% for containing both mutations. Although
this co-transfection was not repeated, the data suggest that
the double mutation is lethal.Discussion
It is now known that IVa2 protein plays a role in both
encapsidation (Zhang and Imperiale, 2000, 2003; Zhang et
al., 2001) and in control of late transcription from the MLP
(Tribouley et al., 1994). HEK-293 cells transfected with an
adenoviral genome containing stop codons at positions 17
and 19 in the ORF for IVa2 yielded no detectable viral
particles, indicating that IVa2 is required for capsid assem-
bly and this function therefore is essential for viral replica-
tion (Zhang and Imperiale, 2003). Infectious virus carrying
the stop codons was produced on 293-IVa2 cells. This virus
was able to express the hexon protein but its expression was
lowered and delayed. However, the transport of viral DNA
to the nucleus was also delayed, with a consequent delay in
the onset of expression of E1A and the 72-kDa DBP, and
thus of DNA replication. Therefore, the contribution of a
direct effect of the loss of IVa2 transcriptional activity on the
reduction in hexon expression could not be assessed, nor
could it be determined if the IVa2 transcriptional function is
also essential for viral replication. Another virus with an
opal codon at position 6 in the ORF for IVa2 was viable and
able to produce a 40-kDa IVa2 isoform (Pardo-Mateos and
Young, 2004). This isoform was capable of binding to
DE1,2 in electrophoretic mobility shift assays (EMSA)
and the virus genome expressed late proteins, although they
accumulated to lower levels than in the vWT-infected cells.
The importance of the MLP DE1,2 elements in the late
activation of transcription has been shown in in vitro
transcription assays (Jansen-Durr et al., 1988; Monde´sert
and Kedinger, 1991; Monde´sert et al., 1992), in an ectopic
placement of an MLP-h-globin construct in the E3 region of
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tion experiments with a MLP-luciferase chimeric reporter
plasmid (Tribouley et al., 1994). The importance of DE1 in
the context of the virus was examined by multiple mutation,
but these had no effect on viral replication either alone or in
combination with a multiple mutation in UPE (Reach et al.,
1991). However, a mutation in both elements DE1 and DE2
was never examined. Thus, we intended to analyze the
effect of this double mutation on viral replication and
deduce from the phenotype the importance of the transcrip-
tional function of IVa2.
A co-transfection of a full-length adenovirus plasmid
containing a lethal mutation in the DNA polymerase gene,
and a shuttle plasmid containing multiple mutations in DE1/
2 (Fig. 1), yielded virus, some of which harbored the DE1/2
mutations. Virus vDE1,2 exhibited a small plaque pheno-
type and slightly lower yields with respect to vWT in one-
step replication assays (Figs. 2A, B). Because DE1,2 are
elements important in late activation of the MLP, a defi-
ciency in late transcription was thought to be responsible for
the deficient replication, due to an inability of IVa2 to bind
to the mutated DE1,2 sequence, as shown in EMSA (Fig. 2).
As expected, there is a small deficiency in accumulation of
late proteins and a corresponding deficiency in the accumu-
lation of late mRNAs that was minor, as it was for the virus
with mutations in the UPE, USF0 (Reach et al., 1990).
The DE1/2 elements lie in the first intron of the tripartite
leader. Thus, it was of concern that the deficiency in late
protein accumulation might be due to a modification in
processing of the primary transcript. A 5V RACE analysis of
the L4-23K mRNA from vDE1,2-infected cells was per-
formed and the product had the same size as that of the
product obtained from vWT (data not shown), suggesting
that processing of the primary RNA transcript was not
affected.
The deficiency in late proteins and mRNAs differs
depending on the specific protein/mRNA (Figs. 4A, B) as
has been observed before with mutations of other MLP
elements (Fessler and Young, 1998; Lu et al., 1997).
Therefore, the deficiency in viral replication can be attrib-
uted to a deficiency in late transcription. This slight pheno-
type may be caused by the lack of IVa2 binding, although
we cannot exclude recruitment of IVa2 to the MLP through
protein–protein interactions with other transactivating pro-
teins (see below).
An unexpected aspect of gene expression in vDE1/2-
infected cells was a reproducible increase in IVa2 expression
both at the protein and mRNA levels (Fig. 4C). The
mechanism underlying this increase is not known, but could
be caused by promoter competition between the MLP and
the IVa2 promoter (Adami and Babiss, 1992; Natarajan et
al., 1985). However, not all virus with transcriptionally
defective MLPs show over-expression of IVa2 (Reach et
al., 1990), and the interesting possibility remains that IVa2
might be over-expressed only in the specific case in which
DE1 and DE2 are mutated. For example, IVa2 proteinbound to DE1,2 might recruit some protein that is also used
to stimulate IVa2 transcription. In the absence of IVa2
binding, the latter protein would be free to stimulate
transcription from the IVa2 promoter.
Previous mutational analysis of the MLP has shown that
the transcription elements exhibit functional redundancy
(reviewed in Young, 2003). Combinations of mutations in
MLP elements in vivo have been shown to have a much
greater phenotype that either one alone. Thus, if the defect
of replication of vDE1,2 is truly caused by deficient MLP
activation, a genome containing these mutations in combi-
nation with another MLP mutated element should exhibit a
more acutely defective phenotype. Precedent for this exists
in vitro and infection/co-transfection experiments. Mutation
of the UPE in a DE1,2 mutated or deleted MLP-luciferase
chimeric reporter plasmid further reduced the late-specific
stimulation of the MLP (Monde´sert et al., 1992). Thus, we
tried to combine mutations in the UPE and DE1/2 into
virus, using two different methods of construction. Viable
virus was never recovered (Table 1). These data show that
DE1/2 and UPE are functionally redundant in the viral
replicative cycle and are strong evidence for an important
role of IVa2 protein in the activation of the MLP. It remains
to be seen if this functional redundancy is caused by direct
or indirect protein–protein interaction between IVa2 protein
and USF.
The availability of a virus genome expressing the 40-
kDa isoform of the IVa2 protein allowed us to test the
viability of genomes containing the opal6 mutation in
combination with mutations in either DE1/2 or the UPE.
We have shown that the isoform, expressed by virus vIVa2
isolate #8, can bind DE1/2, and this binding is not com-
peted by the mutated sequence (data not shown in Pardo-
Mateos and Young, 2004). In other words, the isoform
behaves in binding just as the full-length form. The more
marked viral phenotype of vIVa2, as compared to vDE1/2,
suggests that the vIVa2 phenotype is largely caused by a
deficiency in encapsidation, but it does not address the
ability of the 40-kDa isoform to function in transcription.
The failure to recover virus containing both the opal6 and
DE1/2 mutations (Table 1) implies that the 40-kDa form
present in vIVa2 has a role in transcription. Once the site(s)
to which this isoform can bind is removed, the genome
becomes inviable. The inability to obtain a virus containing
mutations in the UPE (Table 1), and expressing only the 40-
kDa isoform, could be explained in two ways: the 40-kDa
IVa2 isoform, although able to bind the DE1,2 sequence, is
not as efficient as the 55-kDa species in performing the
IVa2 transcriptional activity (as the defect in accumulation
of late proteins in virus vIVa2-infected cells suggests), and
coupled to a deficiency in the binding of USF, reaches a
point where transcription is insufficient for viability. Alter-
natively, the transcriptional deficiency of USF0 coupled to
the encapsidation deficiency of the opal6 mutation might
reach a threshold of nonviability. These explanations are
not mutually exclusive.
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for IVa2 protein in MLP transcription. What is still not clear
is if IVa2 protein is essential to late transcription. As
mentioned above, it is possible that the protein might be
recruited to the mutated DE1/2 sequence by protein–protein
interactions. For this question to be answered, it will be
necessary to create true separation-of-function mutations in
which the essential encapsidation function is maintained,
while the ability to bind, or be recruited to, the DE1/2
elements is abolished. The genetic data further suggest that
the 40-kDa isoform is capable of performing a transcrip-
tional role. Coupled with the results presented elsewhere
(Pardo-Mateos and Young, 2004), it is plausible to suggest
that this isoform is identical to the unidentified 40-kDa
species present in the DEF-A heterodimer (Lutz and
Kedinger, 1996). Further experiments with virus expressing
the 55-kDa isoform only (Pardo-Mateos and Young, 2004)
may help to unravel the requirements for the DEF-A and
DEF-B transcription factors.Materials and methods
Mutant virus construction
As described in detail in Pardo-Mateos and Young
(2004), two different methods were used to create virus.
Briefly, the first system involved recombination in 293 cells
between a shuttle plasmid carrying the desired mutations
and pPM100. The full-length plasmid pPM100 contains a
lethal 8-bp insertion/deletion mutation in the DNA poly-
merase gene at nt 5990. Viable virus will only be produced
if recombination removes the lethal DNA polymerase mu-
tation. If the mutations of interest are not lethal, different
recombinant products can be obtained with a probability
that depends on the position of the crossover and the length
of the fragment where recombination can take place. Fur-
thermore, there is a distinguishable difference in the XhoI
digestion pattern between pPM100 and recombinants de-
rived from recombination with the various shuttle plasmids
described below. They lack the XhoI site at nt 8544 whereas
pPM100 DNA contains it. Recombinant viruses that have
inherited the missing site are likely to have inherited the
MLP mutations present in cis. Plasmids were co-transfected
into 293A cells using the calcium phosphate precipitation
method (Graham and van der Eb, 1973) and cells were
observed for several days until cytopathic effect (cpe) was
detected. If no cpe was observed on the transfection plates,
two more rounds of infection were performed.
The second method involved a system developed by
GenVec Inc. (McVey et al., 2002), in which full-length
adenovirus genomes are produced by recombination between
two linearized plasmids in recA+ recBCD sbcBC E. coli
(see Pardo-Mateos and Young, 2004, for details). The result-
ing mutation-containing plasmids were used to transfect
293A cells. A marker rescue assay with a plasmid carryingthe wild-type sequence for the mutation was performed
routinely in parallel with this transfection. If virus was only
produced from the marker rescue plates, it strongly suggests
that the mutation(s) is lethal. As with the first method,
potential transfection yields were passaged two more times.
Mutagenesis
The shuttle plasmids used for the construction of mutant
viruses, for marker rescue, or both, were as follows:
 pMR2 (Reach et al., 1990) contains Ad5 sequences from
bp 1 to 9523 cloned into the EcoRI and BamHI sites of a
derivative of pBR322, lacking the SphI to SalI fragment
of the vector. It contains unique XhoI and HindIII sites at
nt 5788 and 6241, respectively. These sites flank the
MLP region.
 pDQ1/MLP-USF0 is a derivative of pDQ1 in which the
XhoI to HindIII MLP fragment contains the USF0
mutations. Plasmid pDQ1 has a backbone from pSP64
(Promega, Madison, WI) with an inserted T7 promoter
downstream of the polylinker region, and it contains the
8-bp insertion lethal to DNA polymerase function. Note
that the USF0 mutations remove a distinguishable PmlI
site, a useful marker to follow in the various cloning
steps to be described below.
 pBSK:T30.USF0 contains the XhoI to HindIII MLP
fragment in pBluescript SK II+ (Stratagene, La Jolla,
CA) with the USF0 and TATA30 mutations (Reach et al.,
1991).
 pAP5 (Pardo-Mateos and Young, 2004) contains Ad5
sequences from an AflII site at bp 3533 to an artificial
BamHI site beginning after adenovirus nt 9523 in
pSL180 (Brosius, 1989). It also contains an opal stop
codon at the sixth position of the IVa2 ORF.
Individual mutations were created as follows:
 A plasmid containing mutations in both DE1 and DE2
Mutations in DE1 and DE2 were made in residues whose
methylation interferes with complex formation (Monde´-
sert et al., 1992) while maintaining the same amino acid
reading sequence for the complementary strand encoding
the DNA polymerase (Fig. 1).
Plasmid pDEF carries the DE1 mutations gTTaTC-
cGTcTC in a pMR2 background (Reach et al., 1991).
The mutations were transferred to pBSK:T30.USF0,
resulting in pBSK-DEF. This plasmid was used to
construct the DE2 mutation. A double PCR reaction
was performed using pBSK-DEF as a template. One
reaction contained an upstream primer corresponding to
the plasmid T7 promoter with a mutagenic antisense
primer (oAP4: 5VCAGGTGAATATaAAAagCagtagc
TTTTTGGAg) and a second reaction contained a
downstream T3 promoter primer and the complementary
mutagenic sense primer (oAP3: 5VcTCCAAAAAg-
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were used in conjunction in a second PCR reaction with
the T7 and T3 primers. The final PCR product was
cloned back into the XhoI and HindIII sites of
pBSK:T30.USF0 to create pBSK-DEF1,2. Finally, the
XhoI to HindIII fragment of pBSK-DEF1,2 was
transferred to pMR2, resulting in pMR2-DE1,2.
 Plasmids containing both the USF0 and DE1,2 mutations
The USF0 mutation is a 4-nt change in the UPE from
GGCCACGTGACC to tGCtACaTGgCC. These changes,
which conserve the DNA polymerase amino acid
sequence on the opposite strand and which abrogate
binding of USF, are recoverable in virus (Reach et al.,
1990). To create plasmids containing these mutations and
those of DE1,2, the XhoI to PflMI fragment from pDQ1/
MLP-USF0 was cloned into pBSK-DEF1,2 resulting in
pBSK-DEF1,2/USF0. The HindIII to XhoI fragment was
cloned into pMR2-DE1,2 resulting in pMR2-DE1,2/
USF0.
This plasmid was used to construct a full-length GenVec
plasmid containing the multiple mutations in the UPE
and DE1,2.
 Plasmids containing the DE1,2 and IVa2 opal6 mutations
The pMR2.DE1,2 XhoI to BamHI fragment was cloned
into pAP5, which contains the opal6 mutation in the IVa2
ORF. This resulted in a plasmid (pAP12), carrying Ad5
sequences from bp 3533 to 9523 with the opal6 and
DE1,2 mutations. This plasmid was also used to
construct a full-length GenVec plasmid.
 A plasmid containing the opal6 and USF0 mutations.
The XhoI to HindIII fragment of pDQ1/MLP-USF0 was
cloned into pAP5 resulting in a plasmid carrying Ad5
sequences from bp 3533 to 9523 with the opal6 and
USF0 mutations (pAP13).
Cell culture and viral infection methods
All analyses were conducted with monolayer cultures of
either A549 human lung carcinoma cells or 293A cells, a
subclone of HEK 293 cells (Quantum Biotechnologies Inc.
Montreal, P.Q.). A549 and 293A cells were grown in
Dulbecco’s modification of Eagle’s medium with 10%
‘‘defined/supplemented’’ bovine calf serum or FetalClone
II, respectively (HyClone, Logan, UT), and antibiotics. Cells
to be infected were plated 2 days before the addition of virus
and were confluent when used. Cells were infected at the
multiplicities of infection (MOI) indicated for the individual
experiments. For one-step replication assays, human A549
cells in 35-mm-diameter dishes were infected at a multiplic-
ity of infection (MOI) of 10 fluorescent focus units (FFU)
per cell. After adsorption, the cells were incubated at 37 jC
and at intervals dishes were removed from the incubator and
the entire contents were frozen. Following two more cycles
of freezing and thawing, the samples were titrated by
fluorescent focus assay (Philipson, 1961) and the total
numbers of viruses per cell were calculated. For plaqueassays, cells were plated in 60-mm dishes and, after infec-
tion, overlaid with 10 ml of 2 LP medium containing 0.8%
noble agar (Young et al., 1999). Plaques were photographed
after staining with 0.01% neutral red.
Southern blot analysis
DNA was prepared from infected cells using a modifi-
cation (Volkert and Young, 1983) of the Hirt (1967) method.
After the DNA was digested with XhoI, the samples were
subjected to electrophoresis at 70V in a 1% agarose gel.
After denaturation, the DNA was transferred to a nylon
membrane (NytranN, Schleicher & Schuell, Keene, NH) to
which the DNA was cross-linked by UV light. Filters were
blocked and hybridized to the biotinylated labeled probe
prepared from pAP5, which contains Ad5 sequences from nt
3533 to 9523.
Northern blot analysis
A549 cells in 35-mm dishes were infected at MOI 5 and
harvested at the indicated times postinfection. The isolation
of mRNA and treatment of the samples has been described
in detail previously (Pardo-Mateos and Young, 2004).
Filters were processed essentially as for the Southern
analysis. Biotinylated probes were made by PCR from viral
DNA isolated by the Hirt method in analysis of viral late
mRNAs or using a plasmid fragment carrying adenovirus
sequences from nt 4611 to 5187 for the analysis IVa2
mRNA.
Western blot analysis
A549 cells in 35-mm dishes were infected at MOI 5 and
at the indicated times postinfection protein was isolated by
resuspending the cell pellet in RIPA buffer. 293A cells in
10-cm plates were infected and nuclear extracts (see below)
were prepared at 24 h. Samples (either total protein or
nuclear extracts) were mixed with an equal amount of 2
loading buffer and boiled for 2 min. They were then
subjected to electrophoresis for 3 h at 60 V and transferred
to a nitrocellulose filter (Protran, Schleicher & Schuell). The
filter was blocked overnight and incubated in primary and
secondary antibodies. The primary antibody was diluted
1:2000 in 5% nonfat dry milk in PBS for late proteins and
1:1000 for anti-IVa2 mouse serum. Horseradish peroxidase-
conjugated anti-rabbit or anti-mouse antibodies (Amersham
Biosciences, Amersham, UK) were used as secondary
antibody in a 1:1000 dilution in 5% nonfat dry milk in
PBS. Filters were developed by chemiluminescence with the
Western blotting Luminol Reagent (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA) and exposed to film for up to 1V. For
loading control, a rabbit anti-actin was employed (Sigma-
Aldrich, St. Louis, MO) and the secondary horseradish
peroxidase-conjugated goat anti-rabbit antibody (Santa Cruz
Biotechnology).
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Preparation of nuclear extracts
A modification of the method described by Zhang and
Imperiale (2000) was used. 293A cells in 10-cm plates
were infected at a MOI of 5. Twenty-four hours after
infection, cells were washed twice with PBS, resuspended
in 4 pellet volumes of buffer A containing protease
inhibitors, and incubated on ice for 1 h. The cells were
then transferred to a glass Dounce homogenizer and
subjected to 20 strokes of a tight-fitting pestle. The nuclei
were centrifuged at 2000  g for 5 min at 4 jC. After
being washed once with 1 ml of buffer A, the nuclei were
resuspended in 3 pellet volumes of buffer and incubated on
ice for 30 min. The supernatant was collected after
centrifugation at 12000  g for 10 min, frozen on dry
ice, and stored in aliquots of approximately 200 Al at80 jC.
The details of buffer composition are given elsewhere
(Pardo-Mateos and Young, 2004).
Annealing and labeling of oligonucleotides
To develop a nonradioactive method for EMSA, a pair of
complementary oligonucleotides spanning the IVa2-binding
DE1 and DE2 elements was designed so that the annealed
duplex had 5V extensions of T’s. For the WT sequence,
the oligonucleotides were oAP50: (5VTTTTTCTAA-
GATTGTCAGTTTCCAAAAACGAGGAGGATTTGATA-
TTCACCTG3V) and oAP51: (5VTTT TTCAGGTGAATAT-
CAAATCCTCCTCGTTTTTGGAAACTGACAAT-
CTTAG3V) and for the mutated sequence oAP52:
(5VTTTTTCTAAGgTtaTCcGTcTCCAAAAAgctactGct
TTTtATATTCACCTG3V) and oAP53: (5VTTTTTCA-
GGTGAATATaAAAagCagagcTTTTTGGAgACgG-
AtAAcCTTAG3V). Briefly, after heating the oligonucleo-
tides and allowing them to cool slowly, the duplexes
were labeled at both ends by T4 DNA polymerase using
a dNTP mixture with biotinylated dATP (New England
BioLabs Inc.).
Binding of protein IVa2 to DE1,2 duplexes
Nuclear extracts from vDE1,2-infected cells and from
uninfected cells were incubated in 5 binding buffer [20%
glycerol, 5 mM MgCl2, 2.5 mM EDTA, 2.5 mM DTT, 280
mM NaCl, 50 mM Tris–HCl (pH 7.5)] with 1 Ag Poly dI-
dC per 10 Al reaction for 10 min at room temperature, then
the biotin-labeled duplex oligonucleotides were added to
the reaction and incubated for a further 20 min. Competi-
tion experiments were performed by pre-incubating the
extracts with increasing concentrations of the nonlabeled
WT or mutant duplex oligonucleotide. After adding 10
loading buffer [250 mM Tris–HCl (pH 7.5), 40% glycerol],
the samples were separated by electrophoresis on 6% TBE
gels (PAGEr Gold Precast Gels, Cambrex Bio Science Inc.)
at 250 V in the cold room until the bromophenol blue
running in a marker lane had traveled 3/4 the height of the
gel (approximately 20 min). The gel was transferred viacapillary action for at least 3 h to a nylon membrane
(NytranN, Schleicher & Schuell) in 20 SSC. The filters
were processed and developed as for Southern blotting
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